Hallucinogens causing seizures? A case report of the synthetic amphetamine 2,5-dimethoxy-4-chloroamphetamine.
Mark J Burish, Katie L Thoren, Maura Madou, Shahed Toossi, Maulik Shah
The Neurohospitalist January 2015 DOI: 10.1177/1941874414528939 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | A single patient who took a street-bought hallucinogenic drug thought to be LSD |
| Keywords | Epilepsy Neurochemistry Neuropharmacology Neurotoxicity syndromes Seizures Techniques |
| Key findings | The patient's hallucinations and agitation progressed to status epilepticus, while standard urine toxicology showed only cannabinoids and opioids. Mass spectrometry revealed 2,5-dimethoxy-4-chloroamphetamine. The authors argue that hallucinogenic street drugs missed by standard toxicology can cause unexpected effects such as seizures. |
Abstract
Although traditional hallucinogenic drugs such as marijuana and lysergic acid diethylamide (LSD) are not typically associated with seizures, newer synthetic hallucinogenic drugs can provoke seizures. Here, we report the unexpected consequences of taking a street-bought hallucinogenic drug thought to be LSD. Our patient presented with hallucinations and agitation progressing to status epilepticus with a urine toxicology screen positive only for cannabinoids and opioids. Using liquid chromatography high-resolution mass spectrometry, an additional drug was found: an amphetamine-derived phenylethylamine called 2,5-dimethoxy-4-chloroamphetamine. We bring this to the attention of the neurologic community as there are a growing number of hallucinogenic street drugs that are negative on standard urine toxicology and cause effects that are unexpected for both the patient and the neurologist, including seizures.
Citations in the library
Cited by 11
- Designer drugs: mechanism of action and adverse effects Archives of Toxicology April 1, 2020
- Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens. Current Topics in Behavioral Neurosciences 2017
- The detection and prevention of unintentional consumption of DOx and 25x‐NBOMe at Portugal's Boom Festival Human Psychopharmacology: Clinical and Experimental May 1, 2017
- Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs Frontiers in Psychiatry August 18, 2017
- Psychedelic-related deaths in England, Wales and Northern Ireland (1997-2022). Progress in Neuro-Psychopharmacology and Biological Psychiatry January 10, 2025
and 6 more in the library